Trevi Therapeutics TRVI Q1 2026 Disappoints EPS 009 Below 008 Views Trumps Tariffs Reshape Global Trade Europe Faces a Strategic Crossroads Tencent and Alibaba Sales Miss Estimates as AI Monetization Efforts Face Headwinds Citigroup May Benefit from SP 500 China Banking Talks Analysts Suggest Taiwan Semiconductor Manufacturing TSM Draws Billionaire Interest Amid BofAs Bullish Outlook on Foundry Leadership Establishment ESTA Stock Up 560 Key Resistance at 7268 20260520 Eagle EBMT Q1 2026 Beat Revenue NA EPS Exceeds by Significant AI Dominance Reshapes This Years CNBC Disruptor 50 Valuation Triples to 24 Trillion